Repligen | Bruttoergebnis Vom Umsatz



Gross Profit On Sales Veränderung Datum
Agilent USD 866M 33M 2025-04
Align Technology USD 708.12M 28.01M 2025-06
Bio Techne USD 198.81M 15.74M 2025-06
BioMarin Pharmaceutical USD 670.47M 76.89M 2025-06
Bristol-Myers Squibb USD 8.9B 714M 2025-06
Bruker USD 357.9M 33.3M 2025-06
Charles River Laboratories USD 291.68M 48.42M 2025-06
Danaher USD 3.52B 3M 2025-06
Dentsply International USD 490M 24M 2025-06
Exact Sciences USD 562.45M 61.91M 2025-06
General Electric Aerospace USD 4.02B 286M 2025-06
Henry Schein USD 952M 48M 2025-06
Illumina USD 695M 12M 2025-06
IQVIA Holdings USD 1.05B 251M 2025-06
Mettler Toledo International USD 579.88M 54M 2025-06
Myriad Genetics USD 134.2M 16.7M 2025-03
Pfizer USD 10.88B 248M 2025-06
Repligen USD 91.14M 385K 2025-06
Revvity USD 392.56M 17.01M 2025-06
Standard Biotools USD 21.9M 1.36M 2024-12
Thermo Fisher Scientific USD 4.05B 260M 2025-06
Waters USD 438.02M 53.06M 2025-06
West Pharmaceutical Services USD 273.9M 42M 2025-06


Repligen Bruttoergebnis Vom Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.